David Einhorn - DME Capital Management
Holding/activity history for Coya Therapeutics, Inc. (COYA)
← All COYA superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 2,335,540 | 0.29 | Add 15.28% | 0.04 | $3.71–5.96 · VW $4.62i | $9,202,027 | SEC |
| 2025 Q4 | 2,025,940 | 0.41 | Add 23.05% | 0.08 | $5.25–7.75 · VW $6.20i | $11,750,452 | SEC |
| 2025 Q3 | 1,646,440 | 0.37 | $5.70 | $9,384,708 | SEC | ||
| 2025 Q2 | 1,646,440 | 0.41 | $5.75 | $9,467,030 | SEC | ||
| 2025 Q1 | 1,646,440 | 0.54 | $6.47 | $10,652,466 | SEC | ||
| 2024 Q4 | 1,646,440 | 0.49 | Add 29.23% | 0.11 | $5.07–10.24 · VW $7.16i | $9,434,101 | SEC |
| 2024 Q3 | 1,274,026 | 0.34 | $6.45 | $8,217,467 | SEC | ||
| 2024 Q2 | 1,274,026 | 0.38 | $6.06 | $7,720,598 | SEC | ||
| 2024 Q1 | 1,274,026 | 0.58 | $9.92 | $12,638,338 | SEC | ||
| 2023 Q4 | 1,274,026 | 0.46 | Add 172.19% | 0.29 | $3.21–8.00 · VW $5.89i | $9,440,533 | SEC |
| 2023 Q3 | 468,067 | 0.10 | Add 19.21% | 0.02 | $3.21–5.19 · VW $4.18i | $1,797,377 | SEC |
| 2023 Q2 | 392,647 | 0.07 | $4.07 | $1,598,073 | SEC | ||
| 2023 Q1 | 392,647 | 0.08 | Add 0.05% | $3.68–5.67 · VW $4.41i | $1,560,183 | SEC | |
| 2022 Q4 | 392,444 | 0.13 | Buy | 0.13 | $4.50–4.85 · VW $4.70i IPO/listing quarter |
$1,859,439 | SEC |
Price snapshot:
Current price$4.86
Avg. buy price$5.86
+/- since buy-17.10%
52-week low$3.71
52-week high$7.75